The Vanguard Group 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 08:22 am Sale | 2021-12-31 | 13G | Lifecore Biomedical, Inc. LFCR | The Vanguard Group | 1,257,836 4.270% | -414,005 (-24.76%) | Filing |
| 2021-02-10 11:14 am Purchase | 2020-12-31 | 13G | Lifecore Biomedical, Inc. LFCR | The Vanguard Group | 1,671,841 5.720% | 52,739 (+3.26%) | Filing |